Acrotech Biopharma

Acrotech is a U.S. subsidiary of Aurobindo Pharma (hereinafter referred to as Aurobindo), one of the top three pharmaceutical companies in India in terms of integrated revenue. Acrotech was founded in 2018 as a global platform dedicated to the development and commercialization of innovative patented oncology drugs to meet unmet clinical needs and create value for patients and healthcare stakeholders. It has an extensive sales force and a well-established sales network across all 50 states in the U.S., with rich experience in selling products to community institutions and physicians. Additionally, it can leverage the resources of its parent company, Aurobindo, to enhance its influence.